Krishnendu Ayurveda Hospital

Details

Name :

Krishnendu Ayurveda Hospital

Address  :

Chingoli, Karthikappally

Town  :

Alappuzha

State  :

Kerala

Country  :

INDIA

Post Code:

690 532

Phone  :

91 479 2486337

Fax  :

91 479 2486887

Web URL  :


Description

Knowledge of life was the central principle and mission for late MCKunjuraman Vaidyan 1881 1946 the legendary connoisseur of Ayurveda in founding Sree Rama Krishna Pharmacy widely known as Chingoli Ayurveda Hospital in 1908 He was blessed with rare wisdom accumulated as a disciple of Mootha Koyi Thampuran popularly known as Kerala Vagbhatan of Ananthapuram Palace Haripad

About half a decade after its inauguration by Kerala Panini AR RAJA RAJAVARMA KOYI THAMPURAN this noble cause was further nourished and expanded by the great visionary R Krishnan Vaidyan l9111993 He took his Vaidya Kalanidhi from Government Ayurveda College Trivandrum in 1934 was a member of Board of studies in Ayurveda faculty of Kerala University and above all was widely known and esteemed as a committed physician Chingoli Ayurveda Hospital and Research Centre has flourished with this great heritage of its founders and the deep wisdom accumulated by four generations practicing the divine art of Ayurveda to cure refresh amp replenish Nestled in picturesque ambience in sync with the rhythm of nature which offers exclusive programs that cure a host of ailments replenish the healthy spirit and refresh the human body with its natural vigor and beauty
India has highest oral cancer cases tobacco guilty areca nut too

India has the dubious distinction of having the worlds largest number of oral cancer patients with an annual agestandardised incidence of 125 per 100000 says Dr Pankaj Chaturvedi Associate Professor Department of Head and Neck Oncology Tata Memorial Hospital Mumbai Oral cancer accounts for 94 per cent of all cancers in India oral cancer is not ... Read More

Group B Neisseria meningitidis Vaccine Shows Promise

An investigational vaccine may represent a strong lead in the fight against group B Neisseria meningitidis according to results of a phase 2 study published online in the Lancet Administered in 3 doses over the course of 6 months a new bivalent vaccine was well tolerated and induced a strong immune response against multiple strains of the poten... Read More